Janssen (Netherlands)

Janssen (Netherlands)

Johnson & Johnson Innovative Medicine is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Janssen (Netherlands), Netherlands, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

67%


Total
Publications

1.1K


Total Open
Publications

770


Total
Citations

44K


Open Access
Percentage

67%


Total
Publications

1.1K


Total Open
Publications

770


Total
Citations

44K

Wikipedia

Website

download

Breakdown

24% 37% 6% 33%

Publisher Open

24%

Both

37%

Other Platform Open

6%

Closed

33%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110120Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

277

Hybrid 31%

220

No Guarantees 30%

207

Other Platform Open

Domain 83%

406

Institution 37%

180

Other Internet 10%

48

Public 7%

33

Preprint 5%

26

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
406
Europe PMC
Domain
156
Erasmus University Rotterdam - EUR Research Repository
Institution
35
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
32
Semantic Scholar
Public
31
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
25
Radboud University - Radboud Repository
Institution
23
DOI
Other Internet
22
KU Leuven - Lirias
Institution
19
University of Edinburgh - Edinburgh Research Explorer
Institution
13
1 / 11

Data updated 13 February 2025

Share

Share

Share